Tessera Therapeutics

Ring Therapeutics

Cellarity

Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple transformative human health and sustainability products. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures. The current Flagship ecosystem comprises 44 companies, including Denali Therapeutics, Foghorn Therapeutics, Generate:Biomedicines, Inari, Indigo Agriculture, Moderna, Omega Therapeutics, Sana Biotechnology, Seres Therapeutics, and Tessera Therapeutics. 

Axcella

Omega Therapeutics

Rubius Therapeutics

Sana Biotechnology

Seres Therapeutics

Jinko Solar

Syros Pharmaceuticals

T2 Biosystems

Quanterix

Concert Pharmaceuticals

Denali Therapeutics

Editas Medicine

Sesen Bio

Moderna

BlackDuck

Evelo Biosciences

Codiak Biosciences

Flagship Pioneering

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

Google Font API

Google Analytics

DNSSEC

COO, Pioneering Medicines

Alec Reynolds

Principal Scientist, Protein Science (Immunomimics, Formerly Flagship Labs 72/80)

Alka Agrawal

Director, Administration and Executive Communications, CEO Office

Andrew LaPrade

Executive Partner and CCO

Christine Heenan

Chairperson Norfolk and Norwich - El Viejo Friendship Link

David Trevanion

CEO-Partner

Diego Miralles

Co-Founder, Chairman Emeritus, and Partner Emeritus

Ed Kania

Owner

Erik Jensen

CEO-Partner and Chief Executive Officer of Senda Biosciences

Guillaume Pfefer

CFO, Flagship Labs

Jeff Moore

Daniel Mattes

Paul Navarre

George Church

Aram Adourian

Noubar Afeyan

Founder & CEO

Harry Wilcox

General Partner

Chuck Carelli

Edwin Kania

Stephane Bancel

Senior Partner

Roger Pomerantz

Theo Proukou

Chief HR Officer and Executive Partner

Bill Johnson

Vice President of Finance

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

ZoomInfo provides B2B contact and company information to accelerate the growth of sales and marketing teams.

Black Duck secures and manages open source software worldwide, eliminating open source security vulnerabilities and license compliance pain.

Omega Therapeutics offers a proprietary epigenomic programming platform.

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.

Agios Pharmaceuticals is a biopharmaceutical company discovers and develops therapeutics in the field of cancer metabolism.

Visterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.

Investors Active in Midwestern US

United States Finance Companies (Top 10K)

Late Stage Venture Investors with Investments in New England

Massachusetts Companies With More Than 10 Employees (Top 10K)

Flagship Pioneering conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability. The company accelerates Flagship Pioneering’s advances in biology, engineering, medicine, energy, and beyond. The firm harnesses science and entrepreneurialism to envision alternative futures, beginning with seemingly unreasonable propositions and navigating to transformational outcomes through an evolutionary methodology.

Flagship Pioneering combines innovative capacity, entrepreneurial leadership, and professional capital management in a single enterprise that systematically produces first-in-category companies.

Flagship Pioneering Fund VIII

Flagship Pioneering Fund VII

Special Opportunities Fund II

Flagship Pioneering Fund VI

Special Opportunities Fund

Flagship Ventures Fund V

Flagship Ventures Fund IV

Flagship Ventures Fund III

Flagship Ventures Fund II

Flagship Ventures Fund I

Computer and Software Services and Scientific Services

Cambridge

Massachusetts

United States

North America

GSK Wagers $80M on a Tech Platform and Parkinson’s Drug from Flagship-Founded Vesalius

Chutes & Ladders—Flagship-backed biotechs name new leaders

Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry

Flagship Pioneering’s $3.6 Billion Fundraising

Flagship Pioneering looks to add food production to its bow

GSK Enters Partnership With Flagship Pioneering to Develop Up to 10 New Drugs

GSK: research collaboration with Flagship Pioneering

Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World

Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class

Finland

Europe

Lebanon

Asia

Canada

India

HTML5

Office 365

F5 NGINX

Marketing Consulting

Microsoft Outlook

Google Drive

jQuery

Vimeo

Google Compute Engine

Flagship Pioneering is an American life sciences venture capital company based in Cambridge, Massachusetts that invests in biotechnology, life sciences, health, and sustainability companies. The firm both funds and incubates companies.

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	f0254397
crunchbase profile	general	Nov 22, 2024 8:45 AM	47636f94
li profile	general	Nov 30, 2023 11:50 PM	ee29f82b
translate crunchbase fundingrounds	general	Nov 22, 2024 10:57 AM	4a1b94da
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:FLAGSHIPPIONEERING

Flagship Pioneering